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Introduction
The Astra-8 is a floor-standing seven-channel, automatic,
discrete analyser for use in the clinical chemistry laboratory.
A:t present it will analyse serum for urea, sodium, potassium,
chloride, total carbon dioxide, glucose, and creatinine. It
calculates the anion gap and osmolality, and also the ratio of
blood urea.nitrogen to creatinine when these are expressed as
mg/dl. Urine may be analysed for sodium, potassium, chloride,
glucose and creatinine. Provision is made for the addition of
two further analytical modules when these become available.
The sample tray holds up to 38 specimens and two
calibrating solutions, and requests for up to 76 specimens
may be entered into the machine at one time. Any combin-
ation of available tests may be requested for each specimen
or group of specimens, but sodium and. potassium are always
measured together. The machine may be instructed to
analyse an emergency specimen at any time, after which
it will return to the original sequence of specimens.
The analyser is controlled by a computer to which the
operator communicates by means of a keyboard and a
visual-display unit (VDU). The operator can select individual
tests for each specimen, enter identification numbers, enter
or alter reference ranges, initiate priming of reaction vessels
and automatic calibration on all or any channels, request
duplicate assays, and to return to a control specimen at any
desired frequency. Special procedures for routine maintenance
or diagnosis of faults can be initiated frorn the keyboard.
In addition the computer monitors the functioning of the
instrument, detects the presence of a sample in the cup,
converts the outputs from the analytical modules to analytical
results, expressed either as mass (eg mg/dl) or molar
(eg mmol/1) concentrations. Results are displayed on the
VDU and printed on a high-speed thermal printer in a form
which could be used as the report. This includes the date
and time of the analysis, patient identification number, the
analytical results, the reference ranges, and an indication
if the result is outside that range. The analyser may also be
connected to external data-processing equipment via a
multipin socket.
Reagents provided by the manufacturer are stored on top
of the machine. They are pumped to the reaction Vessels by
peristaltic pumps via preheating elements, and excess is
removed via an overflow. Although the principle components
of each reagent are listed on the bottle, insufficient detail is
given to enable the user to prepare them.
Sodium’ and potassium are measured by means of ion-
selective elects:odes (lithium aluminium silicate glass and
valinomycin respectively). The reference electrode is a
second sodium electrode in contact with a sodium solution
of constant concentration. The electrodes are equilibrated
prior to measurement, and 50/1 of serum or urine are required.
Chloride is measured by coulometric titration with silver
ions released from a silver anode. It requires 8pl of serum or
6/.tl of urine.
Glucose is estimated by measuring the rate of consumption
of oxygen in the presence of glucose oxidase by means of an
oxygen electrode. It requires 10gl of serum or urine.
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Urea is measured from the rate of change of conductivity
in the presence of urease. It requires 10gl of serum. Urine
can be analysed if prediluted with saline to bring the urea
concentration within the range for serum.
Total carbon dioxide is measured by the addition of
sulphuric acid. The carbon dioxide released diffuses through
a membrane and the rate of change of pH in a bicarbonate
bufferis measured. It requires 12gl of serum.
Creatinine is measured by mixing the sample with alkaline
picrate solution and measuring the rate of change of absor-
bance at 520 rim. It requires 30/.tl of serum or 101 of urine.
The minimum volume of serum required for all seven tests
is 175/,tl.
Two aqueous calibration .standards provided by the
manufacturers are each analysed at least twice, and the
result of each analysis is displayed on the basis of the previous
calibration. If the electrical signals satisfy predetermined
criteria, a two-point calibration is performed. If these criteria
are not satisfied each standard may be analysed up to four
times after which an alarm sounds and the operator must
intervene. In this case the reason for the failure to calibrate
is displayed on the VDU, and the operator can then use
diagnostic routines held within the computer to identify
the cause. Forty minutes after a calibration, a warning light
flashes to indicate that the machine will soon need recali-
bration. If no action is taken, the instrument will stop
analysing ten minutes later. The operator can either initiate
a new calibration or override the alarm, after which.the
machine will continue analyses for a further 50 minutes. If
calibration has been overriden, the letters COR are printed
on the report.
A smaller bench-mounted version of the system, the
Astra-4, is available. This has four analytical modules and
no VDU, but has not been examined here.
The RAPid kit is available as an optional extra. This
consists of spare analytical modules and electronic boards
so that in the event of failure the defective unit may be
replaced by the user. The modules are designed to be easy
and quick to replace and the chemistry modules (but not
the electronic boards) may be replaced without switching
the instrument off, thereby retaining volatile memory
within the computer.
A comprehensive manual is provided which describes
the operation and maintenance procedures. The manu-
facturers also arrange training courses for the instrument.
The evaluation
The instrument was obtained on loan from the manufacturers
(Beckman-RIIC Ltd, Cressex Industrial Estate, Turnpike
Road, High Wycombe, Bucks, UK) and evaluated in the
authors’ laboratories between 11 May and 27 June 1979.
Before commencing the evaluation, one of the authors
attended the manufacturers’ training course.
The evaluation followed a recommended protocol as
described by Broughton et al ], although the nature of the
sampling and measurement systems made independent
assessment of these impracticable. The instrument was there-
fore evaluated as a complete system using reagents and
standards supplied by the manufacturer. The aspects evaluated
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included precision, linearity, accuracy, interaction between
channels, and correlation with routine methods. Tests for
interference were made with haemoglobin, bilirubin, methyl
dopa, ethylene-diamine-tetraacetic acid (EDTA), heparin and
fluoride-oxalate. In addition, the effects of hydrochloric acid
and ammonia on urine assays were examined: Carryover
between specimens and from wash fluid to specimens was
also estimated.
At the end of the main evaluation, three chemistry
modules, the sampling module and two electronic boards
were replaced from the RAPid kit to assess the ease of this
procedure. The within-batch precision and linearity of the
system were then rechecked.
Methods
Precision
A normal, human quality control serum was reconstituted
with either water or solutions containing additional analytes
in order to obtain the required concentrations (see Results).
Another control material with low values of most analytes
was used for the lower concentrations. Aliquots of pools of
these sera were analysed twenty times within a single batch
(and within one calibration period). Aliquots were also
stored at -20C and one of each level analysed on each of
twenty working days. The concentrations of each constituent
spanned the analytical range and included clinically important
levels.
Linearity
Aqueous solutions were prepared containing eleven different
concentrations of one analyte, spanning the analytical range
for serum or urine, and constant concentrations of all other
Table 1. Methods used for comparison
Analysis
Urea
Sodium
Potassium
Chloride
Glucose
Creatinine
Creatinine (urine)
Instrument
SA /60
IL 543
IL 543
EEL 920
SMA 12/60
SMA 12/60
Autoanalyser
Method
Diacetylmonoxime
Flame photometry
Flame ,photometry
Coulometric titration
Glucose oxidase
Jaff6 end point
Jaff6 end point
constituents. These solutions were used to tesl: linearity and
any interactions between channels, it was not possible to
keep the chloride concentration constant in the presence of
varying sodium or potassium concentrations or vice versa,
since this would have required nonphysiological levels of
other ions in order to maintain electrical neutrality.
A serum with high concentrations of all analytes was
diluted volumetrically either with water or with another
serum containing relatively low levels to obtain mixtures
with linearly-related concentrations.
Accuracy
Standard solutions were prepared by weighing dried AnalaR
reagents and dissolving these either in water or physiological
saline.
Seven lyophilised sera which had been circulated through
the UK National Quality Control Scheme (NQCS), and three
that had been assayed in the Wellcome Group Quality
Control Programme (WGQCP), were analysed on the Astra
and the results compared with the consensus values from
these schemes.
Comparison with routine methods
Approximately 500 specimens of serum submitted for routine
analysis by the methods listed in Table were also analysed
on the Astra. Only 100 assays for chloride were done, since
in the authors’ laboratory chloride analyses are not performed
in large numbers. No comparison for total carbon dioxide
was made.
Carryover
Sample-to-sample carryover was measured using sera with
high and low concentrations of all analytes ].
Since the sample probes are washed before and after
every sampling, carryover from wash fluid to samples was
assessed by adding procion blue to the wash fluid and
measuring any increase in ,absorbance of the samples.
Interferences
The effects of anticoagulants were assessed by dividing a
blood specimen from a normal volunteer into four aliquots.
One was allowed to clot to produce serum, and an anti-
coagulant was added to each of the other samples and the
plasma separated. The four specimens were then analysed
on all channels.
Table 2. Precision results for serum
Analyte
Urea
(mmol/1)
Sodium
(mmol/1)
Potassium
(mmol/1)
Chloride
(retool/l)
Carbon dioxide
(mmol/l)
Glucose
(mmol/1)
Creatinine
(mol/1)
SD
CV%
Mean
SD
CV%
Mean
SD
CV%
Mean
SD
CV%
Mean
SD
CV%
Mean
SD
CV%
Mean
SD
CV%
Low
2.59
0.16
6.31
124.05
0.83
0.67
2.70
0.02
0.83
82.05
0.51
0.62
11.41
0.14
1.27
1.91
0.04
1.91
89.15
3.47
3.89
Within-batch
7.25
0.17
2.30
144.90
0.55
0.38
4.00
<0.02
<0.5
105.05
0.51
0.49
15.59
0.10
0.65
4.26
<0.05
<1.18
154.70
4.41
2.85
High
17.88
0.16
0.90
164.20
0.41
0.25
5.99
0:02
0.37
125.30
0.73
0.58
29.33
0.39
1.34
7.53
0.09
1.13
300.10
2.79
0.93
High
38.17
0.20
0.53
201.75
0.55
0.27
141.3
0.73
0.52
19.13
0.18
0.93
1848.50
6.22
0.34
Between-batch
Low
2.71
0.21
7.72
121.95
0.95
0.77
2.69
0.04
1.36
83.25
1.12
1.34
10.51
0.33
3.14
1.87
0.06
3.41
95.70
5.20
6.07
Med
’7.22’
0.34*
4.70*
143.40
0.88
0.62
4.10
0.06
1.58
105.70
2.25
2.13
14.31
0.51
3.57
4.26
0.08
1.77
149.40
2.87
1.92
High
18.15
0.36
1.99
163.80
1.47
0.90
6.10
0.06
0.99
126.40
2.70.
2.14
27.94
0.94**
3.37**
7.60
0.09
1.17
291.25
5.79
1.99
V High
38.48
1.46
3.79
201.80
1.51
0.75
141.80
2.28
1.61
18.92
0.29
1.55
1806
24.4
1.35
*These results include a result 6.8 SDs below the mean of the other 19 results. When this result is omitted, the SD is 0.19 and the CV is 2.6%.
**Results showed a downward drift, possibly caused by instability of the specimen.
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The effects of haemolysed erythrocytes,., bilirubin,, and
methyl dopa were assessed by adding each to a serum pool.
The effects of added hydrochloric acid and ammonia on
urine assays was also assessed.
Serum osmolality
This was calculated by the Astra and compared with values
measured by an Osmette osmometer (Precision Systems,
Shuco Scientific Ltd, Halliwick Court Place, Woodhouse
Road, London N 12, UK).
Results
Precision
The results of the precision studies are given in Tables 2 and
3. In a few instances the resolution of the printed result was
such that a reliable estimate of the standard deviation (SD)
could not be obtained. In these cases an upper limit for the
true SD was estimated and this is given in the tables together
with the less-than sign.
Linearity
Using aqueous solutions, results for aI1 channels except total
carbon dioxide were found to be linear over the ranges
stated by the manufacturer. Although the deviation from
linearity for carbon dioxide was statistically significant it
represented a maximum error of only about mmol/1 which
would not be significant clinically.
When serum was diluted with serum, non-linearity was
found for urea above approximately 30 mmol/1 amounting
to about 5 mmol/1 low at 50 mmol/1, and for carbon dioxide
above about 3 5 mmol/1 amounting to approximately 3 mmol/1
low at 50 mmol/1.
Accuracy
Recoveries from standard solutions were between 98.5 and
101.5%. The results of the comparison with external quality
control schemes are given in Table 4.
Comparison with routine methods
Graphs showing the comparison between the Astra results
and those obtained by routine methods are shown for
creatinine in serum in Figure 1, and for potassium in urine
in Figure 2. Essentially similar graphs were obtained for the
other constituents. The coefficients of the regression equations
given in Table 5 include the ratios of variances used in their
computation 2].
Carryover
Carryover from one specimen to the next was undetectable
even when serum followed urine. Carryover from wash fluid
to samples was less than 1/al.
Table 3. Precision results for urine
Analyte
Sodium
Potassium
Chloride
Glucose
Creatinine
SD
CV%
Mean
SD
CV%
Mean
SD
CV%
Mean
SD
CV%
Mean
SD
CV%
Low
(mmol/1)
19.5
<0.5
<2.6
15.23
0.11
0.71
16.70
0.73
4.39
4.64
<0.05
<1.08
2.49
0.04
1.47
Within-batch
(mmol/1)
152.20
0.89
0.59
49.14
0.40
0.82
140.35
0.99
0.70
11.64
0.17
1.46
11.57
0.06
0.49
Interferences
Apart from the expected interferences of fluoride-oxalate
and EDTA on sodium and potassium measurements, the only
interferences observed from anticoagulants were that fluoride-
oxalate produced an !.8% reduction in creatinine at a level
of 87/amol/1; lithium heparin caused a 5.6% reduction in
potassium at a level of4.3 mmol/1;EDTA produced a reduction
of 10.7% in carbon dioxide at 29 mmol/1 and a 6.3% reduction
in. chloride at 105 mmol/1.
Of the other potentially-interfering substances studied,
bilirubin caused a small increase in total carbon dioxide
concentration (5% at 534 flmol/1). It had no observable
effect on creatinine up to a bilirubin concentration of 430
I.tmol/1, but produced an apparent decrease of 20% at a level
of 680mol/1.
Haemolysis at 10 g/1 haemoglobin produced a small
decrease in urea and creatinine which was not statistically
significant.
Methyl dopa caused a. 7% increase in creatinine when
present at 12.5 or 25 mg/1 and a 20% increase at 75 mg/1.
The latter level of methyl dopa is ten times that recorded
following intra-venous infusion; normal therapeutic levels are
usually less than 2.6 mg/1.
Figure 1. Comparison of creatinine in serum
High
(mmol/l)
219.90
0.85
0.39
142.95
1.05
0.73
299.80
1.28
0.43
22.09
0.27
1.21
47.70
0.19
0.40
Low
(mmol/1)
18.35
1.04
5.67
15.42
0.25
1.59
14.88
2.18
14.62
4.60
0.11
2.34
2.51
0.08
3.14
Between-batch
Med
(retool/l)
152.50
1.70
1.12
51.07
1.00
1.96
142.10
2.97
2.09
11.70
0.21
1.82
11.65
0.17
1.46
High
(mmol/1)
215.55
2.93
1.36
141.30
4.23
2.99
294.05
4.11
1.40
21.41
0.37
1.71
46.84
1.02
2.18
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The linearity experiments were designed to detect any
apparent interaction or interference between channels. The
only effect revealed was on the measured value of urea by
sodium, chloride, and bicarbonate. The effect was small but
statistically significant at the 1% level of confidence. For
sodium and chloride there was a decrease of 0.005 mmol/1
of urea for every mmol/1 of sodium or chloride. Over a range
of sodium concentrations of 120-160 mmol/1 the decrease in
serum urea would be 0.22 mmol/1. When chloride and bicar-
bonate concentrations were varied together, keeping the
sodium level constant, no effect on the urea result .was
observed. It seems likely that the cause was the variation
in the ionic strength or initial conductivity of the sample
rather than the sodium concentration itself, but this was not
investigated further.
(iii) During the carryover experiment one triplicate set of
urea resUlts were 3.0, 1.6, 3.0 mmol/1.
(iv) During the linearity study on total carbon dioxide in
which the creatinine concentration was kept constant, a
single result of 47btmol/1 was obtained when the mean of
the other 32 results was 144.4/amol/1, with a coefficient of
variation of 15%. Since all the other analytes assayed precisely
in this experiment, the variability of the creatinine results
could not be attributed to any errors in the preparation of
the solutions.
(v) If urea was measured after a period of inactivity for
that channel, but within the 50-minute calibration period
(such as after assaying a number of urines), low results
were often obtained. It is Understood that the manufacturers
have taken steps to cure this problem.
Serum osmolalities
Calculated serum osmolalities are compared with measured
values in Figure 3. There is broad agreement between the
calculated and the measured values but with one or two
grossly outlying points, especially for a haemolysed sample.
Outlying results
During the evaluation approximately 2000 analyses were
performed on each channel. Some gross outlying results were
obtained for which there was no obvious cause. During the
between-batch precision studies, a result for serum urea of
6.0 retool/1 was obtained, which was 6.8 SD’s below the
mean of 7.3 retool/1 for the other 19 results. In addition,
several outliers were observed during the analysis of specimens
from external quality-control schemes (Table 4):
(i) A result of 0.3 retool/1 for urea was obtained when the
Malfunctions
During the main part of the evaluation there were no
mechanical malfunctions, but there was one malfunction of
the computer, when it behaved irrationally and failed to
Table 4. Accuracy as judged by comparison with consensus
values from external quality control schemes
Analyte
Urea (mmol/1)’
Sodium (mmol/1)
Potassium (mmol/1)
Chloride (mmol/1)
Carbon dioxide
(mmol/1)
Concentration
range of sera
3.8- 28.2
128 161
3.0 8.1
89 120
17.5 23
’Paired Significance* Mean
difference
0.44 2.74 S
+ 2.88 5.41 VS"
+ 0.04 1.27 NS
+ 1.70 4.87 VS
0.71 2.63 S
other four results ranged from 7.8 to 8.3, and a result of Glucose (mmol/1)
10.7 mmol/1 was obtained in a sequence ranging from 9.1 to Creatinine (zmol/1)
9.4.
(ii) Three high chloride results were obtained, but when
repeated agreed with the consensus value. The machine failed
to produce any result for the next five specimens, because
it failed to complete the analysis in the time available,
suggesting that there may have been a fault, although normal
maintenance procedures had been followed. One other assay
gave a chloride result of 104 mmol/1 compared with 96, 96,
97, 97 for the other four.
3.0- 17.4 + 0.002 0.03 NS
71 827 6.0 2.26 NS
Five replicate analyses were made on 10 sera (3 for carbon dioxide)
and mean values for each were compared with the quoted consensus
values.
* NS Not significant at 5% level
S Significant at 5% level
VS Significant at 0.1% level
These results may have been affected by the problems encountered
with this channel (see Discussion}.
20 40 60 80 100 120 140 160
L543) mmol/1
Figure 2. Comparison ofpotassium in urine
0.89 26.56
260
++
++ ++ /
+ .H.’+
+
/-H-
268 292 308 324
Osmette mmol/kg
grossly haemolysed specimen
Figure 3. Comparison o.f osmolality calculated by the
ASTRA with that measured by an osmometer
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respond to commands from the keyboard. The cause was
never established. Pressing the general-reset button cured ,the
problem but caused all the volatile memory within the
computer to be lost.
After the main evaluation was finished, there occurred
two malfunctions of the transport system which carried the
samples to the analytical modules. In both cases the problem
was cleared from the keyboard and the instrument continued
to operate satisfactorily. However, the machine .did not
re-assay the specimen on which it was working at the time
and so these results would have been lost if the operator had
not specifically instructed the machine to return to this
specimen as though it was a new one.
A further intermittent fault occurred in the transport
system on three occasions. Each time the fault cured itself
before the cause could be established.
The RAPid kit
Four modules and two electronic boards from the RAPid kit
were replaced to assess the ease of doing this. The procedure
was simple and took about 30 minutes for a module, most
of which time was spent flushing reagent out of the "defective"
module and repriming the new one. Replacing the. electronic
boards was also easy, taking about 5 minutes. This involved
turning the machine off, so losing volatile memory within
the computer.
Electrical and mechanical construction
Members of the engineering staff examined the machine
without making rigorous mechanical and electrical tests.
The electronic construction and the components used
were judged to be well up to normal commercial practice.
An interlock prevented removal of a perspex cover over the
electronics assembly without switching off the power. Fuses
were labelled with the correct rating and a notice drew
attention to the importance of replacing fuses with the
correct type.
There were adequate precautions to ensure that reagents
spilled in the storage area or leaked from any chemistry
modules would run to waste without entering the electronics
assembly. However, the working area was not well protected
against spillage of samples penetrating to places where .it
would be difficult to remove. The actual surface was of a
type that would wipe clean, butspillages might, for example,
run under the cover of the keyboard. Although trays may be
loaded remote from the machine, the need to key in requests
and patient identification numbers at the keyboard would
make it tempting to load the tray whilst it was in position on
the instrument.
When the main cover is in place over the analytical
modules, the only moving parts to which the operator has
access are the sample tray and the sampling probes. However,
neither of these represented any hazard to the operator.
Cost of reagents
The’ cost of reagents depends very much on the workload
because reagent is. consumed during calibration and auto-
matic-priming cycles. During the night or weekend, if the
machine is not required, most (but not all) reagents can be
replaced by water. Ignoring consumption of reagents for
these purposes, the cost per test varies between 2.4p
(chloride) and 6p (urea). In this evaluation the costs were
approximately twice these figures since the machine was not
subjected to a big workload and comparatively large volumes
were used for priming and calibration.
The training course
A training course for two operators is included in the purchase
price of the instrument. The course provided a comprehensive
guide to both the operation and maintenance of the Astra
system. A booklet provided before the course explained the
basic features of the instrument. The course itself included
detailed instructions, in the principles of each analytical
method, .the operating procedures and trouble shooting.
The operator was given a good theoretical and practical
training in the use of the system and was able to use the
instrument with confidence after its installation.
Discussion
The precision of the instrument on some channels was better
than the resolution of the printer, so that some of the SDs
found were either zero or larger than the correct values.
In either case it has been possible using simulated results to
estimate an upper limit above which the true SDs probably
do not lie, and these are indicated in the tables by the ’less-
than’ sign.
Sodium
This was the only channel with which real difficulties were
experienced. Although potassium is measured within the
same module and uses the same reference electrode, no such
problems were experienced with this test.
During runs of 40 specimens of different sera, there was
evidence of drift but this did not seem to occur when
analysing aqueous solutions or the same serum repeatedly.
The manufacturer was informed, and the module was cleaned
by an engineer who also improved certain electrical con-
nections and replaced both electrodes. It is not possible to be
certain that these modifications removed this problem, but
it has not been mentioned in previous evaluation reports
[3, 4, 5, 6 and 7].
Urea
There seemed to be a disproportionate number of outliers
among serum urea results, although the number is small
compared with the total number of assays performed. There
was little doubt that an assay performed after the module
Table 5. The coefficients of the correlation equations relating the Astra results (y) to those of the routine methods (x)
Analyte
Serum
Urine
Urea
Sodium
Potassium
Chloride
Glucose
Creatinine
Sodium
Potassium
Creatinine
Ratio of
variances
7.12
1.67
4.74
1.0"
0.58
1.10
1.67
4.74
0.80
Slope
0.96
1.03
1.04
0.96
0.93
0.97
1.00
0.97
1.10
95% eonf
limits
+
0.01
0.05
0.01
0.04
0.01
0.01
0.01
0.01
0.01
*Because the vartance of the routine method was not known exactly, this value is assumed.
?Number ofspecimens assayed by both methods.
Intercept
mmol/1 Nf
,’.19
2.1
-0.11
5.8
0.21
4.6 mol/1
1.5 227
0,47 249
0.40 249
459
199
459
100
459
458
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had been unused for some time within the calibration period
could give erroneously low results. This was most likely to
happen if a series of urine samples were analysed followed
by a serum, but the .effect was by no means reproducible.
The manufacturer is aware of this problem, which is probably
caused by deterioration of the reagent in the measuring cup,
and is taking steps to correct it.
Creatinine
The Astra system seems to have overcome many of the
problems associated with the kinetic Jaffe procedure. The
method is precise and free from interference by bilirubin
and haemoglobin except at very high concentrations. The
interference by methyl dopa has been previously described
[3].
Summary and conclusions
With these reservations, the Astra was found to be a precise
and accurate instrument for the measurement of electrolytes,
urea, glucose and creatinine in serum and urine. It is easy to
use, requiring only simple routine maintenance on a daily,
weekly, and monthly routine. In the event of a failure of
almost any part of the system, the RAPid kit enables the
user to replace defective modules easily and quickly. It
could comfortably analyse 200-300 specimens per day and is
therefore particularly suitable for the medium-sized laboratory.
It would also be suitable for use in larger laboratories to
handle emergency specimens by day or night and to back up
a larger multichannel analyser. It is similar in speed and
capability to other instruments but has the advantage of
analysing serum urea, creatinine, glucose, and electrolytes
together and it will also analyse urine specimens.
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should succinctly describe the scope of the contribution and
highlight significant findings or innovations. It should be
written in a style which can easily be translated into French
and German.
The Concise Oxford Dictionary and Fowler’s Modern
English Usage (both published by Oxford University Press)
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recognised, or where a frequently occuring term is
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"flow injection analysis (FIA)..." and the abbreviation used
thereafter. Abbreviations, for standard measures and units
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following the author’s name, i.e. Skeggs [6]. On a separate
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1959, 28, 311.
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